Bellicum Pharmaceuticals' Series A - III Round

Bellicum Pharmaceuticals raised a round of funding on December 15, 2010.

Bellicum Pharmaceuticals is developing stem cell transplant, TCR, and CAR T cell therapies. Its product candidates incorporate molecular switches designed to allow activation or elimination of therape…

Articles about Bellicum Pharmaceuticals' Series A - III Round: